| Stage | HLNE | % of rev | SHAK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $275M | 100.00% | $418M | 100.00% | SHAK ×1.52 |
| Gross profit | $168M | 60.90% | $200M | 47.92% | HLNE +13.0pp |
| Operating income | $126M | 45.93% | $21M | 4.97% | HLNE +41.0pp |
| Pre-tax income | $150M | 54.47% | $23M | 5.46% | HLNE +49.0pp |
| Net income | $125M | 45.36% | $17M | 4.04% | HLNE +41.3pp |
| Stage | HLNE | SHAK | Gap · A − B |
|---|---|---|---|
| Revenue | $275M100.00% | $418M100.00% | SHAK ×1.52 |
| Gross profit | 60.90%$168M | 47.92%$200M | HLNE +13.0pp |
| Operating income | 45.93%$126M | 4.97%$21M | HLNE +41.0pp |
| Pre-tax income | 54.47%$150M | 5.46%$23M | HLNE +49.0pp |
| Net income |
| 45.36%$125M |
| 4.04%$17M |
| HLNE +41.3pp |
No shared counterparties.